Virios therapeutics announces third quarter 2023 financial results and provides corporate update

- conference call today at 8:30 a.m. et - atlanta, nov. 13, 2023 (globe newswire) -- virios therapeutics, inc. (nasdaq: viri) (the “company”), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic diseases, including fibromyalgia (“fm”) and long-covid (“lc”), today announced financial results for the third quarter ended september 30, 2023.
VIRI Ratings Summary
VIRI Quant Ranking